Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis
about
Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis
description
clinical trial
@en
klinisch onderzoek
@nl
name
Nivolumab in Treating Patients ...... olycythemia Vera Myelofibrosis
@en
type
label
Nivolumab in Treating Patients ...... olycythemia Vera Myelofibrosis
@en
prefLabel
Nivolumab in Treating Patients ...... olycythemia Vera Myelofibrosis
@en
P1050
P1476
Phase 2 Study of Nivolumab in ...... olycythemia Vera Myelofibrosis
@en
P3098
NCT02421354
P580
2015-05-14T00:00:00Z
P582
2018-04-13T00:00:00Z